Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 3, Pages 506-517
Publisher
Wiley
Online
2016-10-13
DOI
10.1002/art.39953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire)
- (2016) Nibah Fatimah et al. CLINICAL RHEUMATOLOGY
- Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
- (2016) Y. Tanaka et al. JOURNAL OF RHEUMATOLOGY
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
- (2014) Edward C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
- (2014) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort
- (2014) Elena Nikiphorou et al. CLINICAL RHEUMATOLOGY
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Advanced multiplicity adjustment methods in clinical trials
- (2013) Mohamed Alosh et al. STATISTICS IN MEDICINE
- Current Understanding of Rheumatoid Arthritis Therapy
- (2012) I Colmegna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- The AMBITION trial: tocilizumab monotherapy for rheumatoid arthritis
- (2010) Graeme Jones Expert Review of Clinical Immunology
- Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
- (2009) RF van Vollenhoven et al. LANCET
- A graphical approach to sequentially rejective multiple test procedures
- (2008) Frank Bretz et al. STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now